Quick Answer
Aura Biosciences, Inc. reported Stockholders Equity of $136.91 million for fiscal year 2025.
Aura Biosciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $136.91M | -9.9% |
| 2024 | $151.97M | -32.7% |
| 2023 | $225.85M | +15.5% |
| 2022 | $195.58M | +28.4% |
| 2021 | $152.31M | +240.1% |
| 2020 | -$108.71M | -24.4% |
| 2019 | -$87.41M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $156.67M | -10.3% | -10.3% |
| June 30, 2025 | $174.63M | -8.8% | +36.5% |
| March 31, 2025 | $127.97M | -38.7% | -15.8% |
| December 31, 2024 | $151.97M | -32.7% | -13.0% |
| September 30, 2024 | $174.67M | +15.1% | -8.8% |
| June 30, 2024 | $191.45M | +15.0% | -8.3% |
| March 31, 2024 | $208.78M | +15.8% | -7.6% |
| December 31, 2023 | $225.85M | +15.5% | +48.9% |
- Aura Biosciences, Inc. showed a decrease of -9.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Aura Biosciences, Inc.’s stockholders equity has grown by 256.6% (from -$87.41 million to $136.91 million).
- The most recent figure is from Aura Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: